Cargando…

The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors

BACKGROUND: The BRAF(V600E) mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAF(V600E) mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Sun Yi, Park, HeonSoo, Kang, Myung Koo, Lee, Dong Kun, Lee, Kang Dae, Lee, Hyoung Shin, Kim, Sung Won, Lee, Eun Nam, Hong, Jong Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833185/ https://www.ncbi.nlm.nih.gov/pubmed/24228637 http://dx.doi.org/10.1186/1477-7819-11-291

Ejemplares similares

Association between BRAF(V600E) mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
por: Lu, Hai-Zhen, et al.
Publicado: (2017)

Correlation between Ultrasonographic Appearance of Papillary Thyroid Microcarcinoma and BRAF V600E Mutation
por: Liang, Songnian, et al.
Publicado: (2022)

Impact of Clinicopathologic Factors on Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
por: Kim, Bo-Yeon, et al.
Publicado: (2012)

Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAF(V600E) Mutational Status and Expression of Angiogenic Factors
por: Shi, Chenlei, et al.
Publicado: (2016)

Association between BRAF(V600E) mutation and the clinicopathological features in incidental papillary thyroid microcarcinoma: A single-center study in Turkish patients
por: Sezer, Havva, et al.
Publicado: (2020)

Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
por: Lee, Cho Rok, et al.
Publicado: (2017)

Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation
por: Lee, Doh Young, et al.
Publicado: (2017)

Clinical Outcome, Role of BRAF(V600E), and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?
por: Nucera, Carmelo, et al.
Publicado: (2012)

Association of BRAF(V600E) Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies
por: Attia, Abdallah S., et al.
Publicado: (2022)

Diagnostic Efficacy of Ultrasound, Cytology, and BRAF(V600E) Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma
por: Du, Jing, et al.
Publicado: (2022)

Papillary Thyroid Microcarcinomas Are Different from Latent Papillary Thyroid Carcinomas at Autopsy
por: Lee, Yong Sang, et al.
Publicado: (2014)

Clinicopathological characteristics and recurrence risk of papillary thyroid microcarcinoma in the elderly
por: Wang, Xiaofei, et al.
Publicado: (2019)

Multifocality and Bilaterality of Papillary Thyroid Microcarcinoma
por: So, Yoon Kyoung, et al.
Publicado: (2015)

TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea
por: Kim, Min Jhi, et al.
Publicado: (2022)

Papillary Thyroglossal Duct Cyst Carcinoma with Synchronous Occult Papillary Thyroid Microcarcinoma
por: Park, Min-Ho, et al.
Publicado: (2010)

Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma
por: Song, Young Shin, et al.
Publicado: (2020)

Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma
por: ZHANG, XIAO-LI, et al.
Publicado: (2014)

Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma
por: Zhou, Changxin, et al.
Publicado: (2019)

Treatment for papillary thyroid microcarcinoma
por: Shi, Lan, et al.
Publicado: (2013)

Prevalence of BRAF(V600E) Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAF(V600E) Prevalent Area
por: Kim, Hyereen, et al.
Publicado: (2018)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Detection of Plasma BRAF(V600E) Mutation Is Associated with Lung Metastasis in Papillary Thyroid Carcinomas
por: Kim, Bo Hyun, et al.
Publicado: (2015)

Real-Time PCR Cycle Threshold Values for the BRAF(V600E) Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study
por: Park, Vivian Y., et al.
Publicado: (2015)

Papillary thyroid microcarcinoma in a thyroid pyramidal lobe
por: Ha, Tae Kwun, et al.
Publicado: (2014)

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
por: Kang, So Young, et al.
Publicado: (2013)

Is Routine Central Neck Dissection Necessary for the Treatment of Papillary Thyroid Microcarcinoma?
por: Choi, Se Jun, et al.
Publicado: (2008)

High Preponderance of BRAF V600E Mutation in Papillary Thyroid Carcinoma Among Filipinos: A Clinicopathologic Study
por: Espiritu, Gerard Anthony M., et al.
Publicado: (2019)

Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Braf(v600e) Mutation: A Single Center Study of 1,207 Chinese Patients
por: Xue, Shuai, et al.
Publicado: (2019)

Associations of the BRAF(V600E) Mutation with Sonographic Features and Clinicopathologic Characteristics in a Large Population with Conventional Papillary Thyroid Carcinoma
por: Park, Ah Young, et al.
Publicado: (2014)

Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma
por: Kim, Soo-Yeon, et al.
Publicado: (2017)

Insights into the Management of Papillary Microcarcinoma of the Thyroid
por: Miyauchi, Akira, et al.
Publicado: (2018)

Papillary thyroid microcarcinoma (Black Ink)
por: Trapanese, Ersilio, et al.
Publicado: (2018)

Unusual Metastases in Papillary Microcarcinoma of Thyroid
por: Nimmagadda, Ajit, et al.
Publicado: (2019)

Surgical Treatment in Papillary Thyroid Microcarcinoma
por: Tunca, Fatih, et al.
Publicado: (2018)

Radiofrequency Ablation of Papillary Thyroid Microcarcinomas
por: Rangel, Leonardo Guimarães, et al.
Publicado: (2022)

Active Surveillance or Surgery in Papillary Thyroid Microcarcinoma: An Ongoing Controversy
por: Won, Ho-Ryun, et al.
Publicado: (2022)

Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma
por: Bo, Xiao-Wan, et al.
Publicado: (2020)

Cross-Regulation between Oncogenic BRAF(V600E) Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma
por: Lee, Seong Jin, et al.
Publicado: (2011)

The BRAF(V600E) mutation in papillary thyroid microcarcinoma with intermediate-risk to high-risk features: does the mutation have an effect on clinical response to radioiodine therapy?
por: Shen, Guohua, et al.
Publicado: (2019)

A multivariable model of BRAF(V600E) and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma
por: Chen, Bao-Ding, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gjlici7lrl4hcaktermmtss337